The Effect of the Oral Contraceptive Pill on Acute Glycaemic Response to an Oral Glucose Bolus in Healthy Young Women: A Randomised Crossover Study
The oral contraceptive pill (OCP) is widely used by women worldwide, yet the influence of the OCP on carbohydrate metabolism remains under-investigated, with existing studies being few and largely cross-sectional. The study objective was to assess, for the first time, the effect of the combined OCP...
Gespeichert in:
Veröffentlicht in: | Nutrients 2024-10, Vol.16 (20), p.3490 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 20 |
container_start_page | 3490 |
container_title | Nutrients |
container_volume | 16 |
creator | Cree, Julia M E Brennan, Niamh M Poppitt, Sally D Miles-Chan, Jennifer L |
description | The oral contraceptive pill (OCP) is widely used by women worldwide, yet the influence of the OCP on carbohydrate metabolism remains under-investigated, with existing studies being few and largely cross-sectional. The study objective was to assess, for the first time, the effect of the combined OCP on postprandial glycaemic response to an oral glucose bolus, using a randomised crossover design.
The effect of a combined monophasic OCP phase on glucose homeostasis and metabolic profile was investigated in 21 healthy young women, who were regular users of either androgenic or anti-androgenic OCP formulations. Plasma glycaemic markers (glucose, insulin and C-peptide) were assessed prior to a 60 g glucose drink (fasting) and for a further 4 h postprandially; once during the "active" (hormone-containing) pill phase and once during the "inactive" (hormone-free) pill phase of the OCP usage cycle.
Despite no change in fasting values, in androgenic pill users, postprandial glucose and insulin responses to an oral glucose bolus were ~100% and ~50% greater, respectively, during the active versus inactive phase. In contrast, in anti-androgenic pill users there was no significant change in response between the two OCP usage cycle phases.
These findings highlight an acute, but potentially detrimental, influence of the combined OCP on glucose homeostasis, particularly in users of formulations containing androgenic progestogens. Given the high global prevalence of OCP use and increasingly common prolonged active pill regimens, which may continue for months, years or even decades, potential cumulative effects of such changes on metabolic risk demand further investigation. |
doi_str_mv | 10.3390/nu16203490 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11510745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A814405199</galeid><sourcerecordid>A814405199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c327t-bf98749fa9ede78f33a9a713e92e55077bf5f1fa6e62b564526a37bf2d27bfe03</originalsourceid><addsrcrecordid>eNptkl1rFDEUhgdRbKm98QdIwBsRtuZzZuKNrEu7LRQqtSJehezMyW5KNtlOkoX9Hf5hM2zth5hAPk6e88Kbc6rqLcEnjEn8yWdSU8y4xC-qQ4obOqlrzl4-OR9UxzHe4nE0uKnZ6-qASS5a3orD6vfNCtCpMdAlFAxK5XY1aIdmwadBd7BJdgvom3UOBY-mXU6A5m7XaVjbDl1D3AQfAaWAtN9nzl3uQgl9DS5HZD06B-3Saod-heyX6GdYg_-Mpuha-z6sbYQezYYQY9jCgL6n3O_eVK-MdhGO7_ej6sfZ6c3sfHJ5Nb-YTS8nHaNNmiyMbBsujZbQQ9MaxrTUDWEgKQiBm2ZhhCFG11DThai5oLVmJUh7WlbA7Kj6stfd5MUa-g5Gy05tBrvWw04FbdXzF29Xahm2ihBBcMNFUfhwrzCEuwwxqWKoA-e0h5CjYoQSXHPSjuj7f9DbkAdf_I1UqVXNJX2kltqBst6EsQqjqJq2hHMsiJSFOvkPVWY_ViV4MLbEnyV83Cd0408PYB5MEqzGNlKPbVTgd0-_5QH92zTsDyH_we8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3120726492</pqid></control><display><type>article</type><title>The Effect of the Oral Contraceptive Pill on Acute Glycaemic Response to an Oral Glucose Bolus in Healthy Young Women: A Randomised Crossover Study</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Cree, Julia M E ; Brennan, Niamh M ; Poppitt, Sally D ; Miles-Chan, Jennifer L</creator><creatorcontrib>Cree, Julia M E ; Brennan, Niamh M ; Poppitt, Sally D ; Miles-Chan, Jennifer L</creatorcontrib><description>The oral contraceptive pill (OCP) is widely used by women worldwide, yet the influence of the OCP on carbohydrate metabolism remains under-investigated, with existing studies being few and largely cross-sectional. The study objective was to assess, for the first time, the effect of the combined OCP on postprandial glycaemic response to an oral glucose bolus, using a randomised crossover design.
The effect of a combined monophasic OCP phase on glucose homeostasis and metabolic profile was investigated in 21 healthy young women, who were regular users of either androgenic or anti-androgenic OCP formulations. Plasma glycaemic markers (glucose, insulin and C-peptide) were assessed prior to a 60 g glucose drink (fasting) and for a further 4 h postprandially; once during the "active" (hormone-containing) pill phase and once during the "inactive" (hormone-free) pill phase of the OCP usage cycle.
Despite no change in fasting values, in androgenic pill users, postprandial glucose and insulin responses to an oral glucose bolus were ~100% and ~50% greater, respectively, during the active versus inactive phase. In contrast, in anti-androgenic pill users there was no significant change in response between the two OCP usage cycle phases.
These findings highlight an acute, but potentially detrimental, influence of the combined OCP on glucose homeostasis, particularly in users of formulations containing androgenic progestogens. Given the high global prevalence of OCP use and increasingly common prolonged active pill regimens, which may continue for months, years or even decades, potential cumulative effects of such changes on metabolic risk demand further investigation.</description><identifier>ISSN: 2072-6643</identifier><identifier>EISSN: 2072-6643</identifier><identifier>DOI: 10.3390/nu16203490</identifier><identifier>PMID: 39458485</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adolescent ; Adult ; Blood Glucose - analysis ; C-Peptide - blood ; Carbohydrates ; Complications and side effects ; Contraceptives, Oral - administration & dosage ; Contraceptives, Oral - pharmacology ; Contraceptives, Oral, Combined - administration & dosage ; Cross-Over Studies ; Diabetes ; Disease ; Female ; Glucose ; Glucose - administration & dosage ; Glucose - metabolism ; Health aspects ; Hormones ; Humans ; Hypertension ; Insulin ; Insulin - blood ; Medical research ; Medicine, Experimental ; Metabolic syndrome X ; Metabolism ; Oral contraceptives ; Peptides ; Physiological aspects ; Plasma ; Postprandial Period ; Questionnaires ; Risk factors ; Software ; Thermogenesis ; Women ; Womens health ; Young Adult</subject><ispartof>Nutrients, 2024-10, Vol.16 (20), p.3490</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c327t-bf98749fa9ede78f33a9a713e92e55077bf5f1fa6e62b564526a37bf2d27bfe03</cites><orcidid>0000-0002-2214-8378 ; 0000-0003-0313-7048 ; 0000-0002-3926-1510</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11510745/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11510745/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39458485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cree, Julia M E</creatorcontrib><creatorcontrib>Brennan, Niamh M</creatorcontrib><creatorcontrib>Poppitt, Sally D</creatorcontrib><creatorcontrib>Miles-Chan, Jennifer L</creatorcontrib><title>The Effect of the Oral Contraceptive Pill on Acute Glycaemic Response to an Oral Glucose Bolus in Healthy Young Women: A Randomised Crossover Study</title><title>Nutrients</title><addtitle>Nutrients</addtitle><description>The oral contraceptive pill (OCP) is widely used by women worldwide, yet the influence of the OCP on carbohydrate metabolism remains under-investigated, with existing studies being few and largely cross-sectional. The study objective was to assess, for the first time, the effect of the combined OCP on postprandial glycaemic response to an oral glucose bolus, using a randomised crossover design.
The effect of a combined monophasic OCP phase on glucose homeostasis and metabolic profile was investigated in 21 healthy young women, who were regular users of either androgenic or anti-androgenic OCP formulations. Plasma glycaemic markers (glucose, insulin and C-peptide) were assessed prior to a 60 g glucose drink (fasting) and for a further 4 h postprandially; once during the "active" (hormone-containing) pill phase and once during the "inactive" (hormone-free) pill phase of the OCP usage cycle.
Despite no change in fasting values, in androgenic pill users, postprandial glucose and insulin responses to an oral glucose bolus were ~100% and ~50% greater, respectively, during the active versus inactive phase. In contrast, in anti-androgenic pill users there was no significant change in response between the two OCP usage cycle phases.
These findings highlight an acute, but potentially detrimental, influence of the combined OCP on glucose homeostasis, particularly in users of formulations containing androgenic progestogens. Given the high global prevalence of OCP use and increasingly common prolonged active pill regimens, which may continue for months, years or even decades, potential cumulative effects of such changes on metabolic risk demand further investigation.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Blood Glucose - analysis</subject><subject>C-Peptide - blood</subject><subject>Carbohydrates</subject><subject>Complications and side effects</subject><subject>Contraceptives, Oral - administration & dosage</subject><subject>Contraceptives, Oral - pharmacology</subject><subject>Contraceptives, Oral, Combined - administration & dosage</subject><subject>Cross-Over Studies</subject><subject>Diabetes</subject><subject>Disease</subject><subject>Female</subject><subject>Glucose</subject><subject>Glucose - administration & dosage</subject><subject>Glucose - metabolism</subject><subject>Health aspects</subject><subject>Hormones</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Insulin</subject><subject>Insulin - blood</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Metabolic syndrome X</subject><subject>Metabolism</subject><subject>Oral contraceptives</subject><subject>Peptides</subject><subject>Physiological aspects</subject><subject>Plasma</subject><subject>Postprandial Period</subject><subject>Questionnaires</subject><subject>Risk factors</subject><subject>Software</subject><subject>Thermogenesis</subject><subject>Women</subject><subject>Womens health</subject><subject>Young Adult</subject><issn>2072-6643</issn><issn>2072-6643</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkl1rFDEUhgdRbKm98QdIwBsRtuZzZuKNrEu7LRQqtSJehezMyW5KNtlOkoX9Hf5hM2zth5hAPk6e88Kbc6rqLcEnjEn8yWdSU8y4xC-qQ4obOqlrzl4-OR9UxzHe4nE0uKnZ6-qASS5a3orD6vfNCtCpMdAlFAxK5XY1aIdmwadBd7BJdgvom3UOBY-mXU6A5m7XaVjbDl1D3AQfAaWAtN9nzl3uQgl9DS5HZD06B-3Saod-heyX6GdYg_-Mpuha-z6sbYQezYYQY9jCgL6n3O_eVK-MdhGO7_ej6sfZ6c3sfHJ5Nb-YTS8nHaNNmiyMbBsujZbQQ9MaxrTUDWEgKQiBm2ZhhCFG11DThai5oLVmJUh7WlbA7Kj6stfd5MUa-g5Gy05tBrvWw04FbdXzF29Xahm2ihBBcMNFUfhwrzCEuwwxqWKoA-e0h5CjYoQSXHPSjuj7f9DbkAdf_I1UqVXNJX2kltqBst6EsQqjqJq2hHMsiJSFOvkPVWY_ViV4MLbEnyV83Cd0408PYB5MEqzGNlKPbVTgd0-_5QH92zTsDyH_we8</recordid><startdate>20241015</startdate><enddate>20241015</enddate><creator>Cree, Julia M E</creator><creator>Brennan, Niamh M</creator><creator>Poppitt, Sally D</creator><creator>Miles-Chan, Jennifer L</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2214-8378</orcidid><orcidid>https://orcid.org/0000-0003-0313-7048</orcidid><orcidid>https://orcid.org/0000-0002-3926-1510</orcidid></search><sort><creationdate>20241015</creationdate><title>The Effect of the Oral Contraceptive Pill on Acute Glycaemic Response to an Oral Glucose Bolus in Healthy Young Women: A Randomised Crossover Study</title><author>Cree, Julia M E ; Brennan, Niamh M ; Poppitt, Sally D ; Miles-Chan, Jennifer L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c327t-bf98749fa9ede78f33a9a713e92e55077bf5f1fa6e62b564526a37bf2d27bfe03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Blood Glucose - analysis</topic><topic>C-Peptide - blood</topic><topic>Carbohydrates</topic><topic>Complications and side effects</topic><topic>Contraceptives, Oral - administration & dosage</topic><topic>Contraceptives, Oral - pharmacology</topic><topic>Contraceptives, Oral, Combined - administration & dosage</topic><topic>Cross-Over Studies</topic><topic>Diabetes</topic><topic>Disease</topic><topic>Female</topic><topic>Glucose</topic><topic>Glucose - administration & dosage</topic><topic>Glucose - metabolism</topic><topic>Health aspects</topic><topic>Hormones</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Insulin</topic><topic>Insulin - blood</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Metabolic syndrome X</topic><topic>Metabolism</topic><topic>Oral contraceptives</topic><topic>Peptides</topic><topic>Physiological aspects</topic><topic>Plasma</topic><topic>Postprandial Period</topic><topic>Questionnaires</topic><topic>Risk factors</topic><topic>Software</topic><topic>Thermogenesis</topic><topic>Women</topic><topic>Womens health</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cree, Julia M E</creatorcontrib><creatorcontrib>Brennan, Niamh M</creatorcontrib><creatorcontrib>Poppitt, Sally D</creatorcontrib><creatorcontrib>Miles-Chan, Jennifer L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nutrients</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cree, Julia M E</au><au>Brennan, Niamh M</au><au>Poppitt, Sally D</au><au>Miles-Chan, Jennifer L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effect of the Oral Contraceptive Pill on Acute Glycaemic Response to an Oral Glucose Bolus in Healthy Young Women: A Randomised Crossover Study</atitle><jtitle>Nutrients</jtitle><addtitle>Nutrients</addtitle><date>2024-10-15</date><risdate>2024</risdate><volume>16</volume><issue>20</issue><spage>3490</spage><pages>3490-</pages><issn>2072-6643</issn><eissn>2072-6643</eissn><abstract>The oral contraceptive pill (OCP) is widely used by women worldwide, yet the influence of the OCP on carbohydrate metabolism remains under-investigated, with existing studies being few and largely cross-sectional. The study objective was to assess, for the first time, the effect of the combined OCP on postprandial glycaemic response to an oral glucose bolus, using a randomised crossover design.
The effect of a combined monophasic OCP phase on glucose homeostasis and metabolic profile was investigated in 21 healthy young women, who were regular users of either androgenic or anti-androgenic OCP formulations. Plasma glycaemic markers (glucose, insulin and C-peptide) were assessed prior to a 60 g glucose drink (fasting) and for a further 4 h postprandially; once during the "active" (hormone-containing) pill phase and once during the "inactive" (hormone-free) pill phase of the OCP usage cycle.
Despite no change in fasting values, in androgenic pill users, postprandial glucose and insulin responses to an oral glucose bolus were ~100% and ~50% greater, respectively, during the active versus inactive phase. In contrast, in anti-androgenic pill users there was no significant change in response between the two OCP usage cycle phases.
These findings highlight an acute, but potentially detrimental, influence of the combined OCP on glucose homeostasis, particularly in users of formulations containing androgenic progestogens. Given the high global prevalence of OCP use and increasingly common prolonged active pill regimens, which may continue for months, years or even decades, potential cumulative effects of such changes on metabolic risk demand further investigation.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39458485</pmid><doi>10.3390/nu16203490</doi><orcidid>https://orcid.org/0000-0002-2214-8378</orcidid><orcidid>https://orcid.org/0000-0003-0313-7048</orcidid><orcidid>https://orcid.org/0000-0002-3926-1510</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-6643 |
ispartof | Nutrients, 2024-10, Vol.16 (20), p.3490 |
issn | 2072-6643 2072-6643 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11510745 |
source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
subjects | Adolescent Adult Blood Glucose - analysis C-Peptide - blood Carbohydrates Complications and side effects Contraceptives, Oral - administration & dosage Contraceptives, Oral - pharmacology Contraceptives, Oral, Combined - administration & dosage Cross-Over Studies Diabetes Disease Female Glucose Glucose - administration & dosage Glucose - metabolism Health aspects Hormones Humans Hypertension Insulin Insulin - blood Medical research Medicine, Experimental Metabolic syndrome X Metabolism Oral contraceptives Peptides Physiological aspects Plasma Postprandial Period Questionnaires Risk factors Software Thermogenesis Women Womens health Young Adult |
title | The Effect of the Oral Contraceptive Pill on Acute Glycaemic Response to an Oral Glucose Bolus in Healthy Young Women: A Randomised Crossover Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T20%3A53%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effect%20of%20the%20Oral%20Contraceptive%20Pill%20on%20Acute%20Glycaemic%20Response%20to%20an%20Oral%20Glucose%20Bolus%20in%20Healthy%20Young%20Women:%20A%20Randomised%20Crossover%20Study&rft.jtitle=Nutrients&rft.au=Cree,%20Julia%20M%20E&rft.date=2024-10-15&rft.volume=16&rft.issue=20&rft.spage=3490&rft.pages=3490-&rft.issn=2072-6643&rft.eissn=2072-6643&rft_id=info:doi/10.3390/nu16203490&rft_dat=%3Cgale_pubme%3EA814405199%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3120726492&rft_id=info:pmid/39458485&rft_galeid=A814405199&rfr_iscdi=true |